Responsible Translational Pathways for Germline Gene Editing?
Sponsor
Work on this paper was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R03HG010417. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.
Published In
Current Stem Cell Reports
Document Type
Citation
Publication Date
8-21-2020
Abstract
Continued development of gene editing techniques has raised the real possibility of clinical application of germline gene editing. These results, as well as reports of an unethical experiment which resulted in the birth of at least two children from edited embryos in 2018, have highlighted the urgency and importance of ethical issues about translational pathways for editing of human germline cells. Charting responsible translational pathways for germline gene editing requires tackling some significant and complex ethical issues.
Locate the Document
DOI
10.1007/s40778-020-00179-x
Persistent Identifier
https://archives.pdx.edu/ds/psu/33708
Citation Details
Cwik, B. (2020). Responsible Translational Pathways for Germline Gene Editing? Current Stem Cell Reports. https://doi.org/10.1007/s40778-020-00179-x
Description
© Springer Nature Switzerland AG 2020.